Guardian Bio Analysis: $500K Raised

What is Guardian Bio?

Guardian Bio combines regenerative medicine with immunotherapy to restore anti-cancer immunity in late-stage solid tumor patients through innovative dendritic cell therapy.

Product Features & Capabilities

• Guard-cDC1s generated from patient’s own stem cells, capable of restoring dysfunctional antigen presentation, stimulate against multiple targets simultaneously, activate various effector cells.

How much Guardian Bio raised

Who are the founders of Guardian Bio

Investors